Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (NICE technology appraisal guidance 90)

Stewart, K., Walters, M. and Dawson, J. (2011) Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (NICE technology appraisal guidance 90). Heart, 97(7), pp. 585-586. (doi:10.1136/hrt.2010.219717)

Full text not currently available from Enlighten.

Publisher's URL: http://dx.doi.org/10.1136/hrt.2010.219717

Abstract

The National Institute for Health and Clinical Excellence has recently published an update of technology appraisal guidance 90, first published in 2005, which evaluated the use of clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events. This article considers the update in detail and discusses the implications for clinical practice

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Dawson, Professor Jesse
Authors: Stewart, K., Walters, M., and Dawson, J.
College/School:College of Medical Veterinary and Life Sciences
Journal Name:Heart
ISSN:1355-6037

University Staff: Request a correction | Enlighten Editors: Update this record